The Panel agrees with the Complainant's assertion that the domain name at issue lexapro.site is identical to the Complainant’s trademark “LEXAPRO”.
In fact the domain name at issue corresponds to the Complainant’s LEXAPRO mark, apart from the “.site” generic top level domain.
The Complainant claims (and this Panel agrees), that the incorporation of its trademark in its entirety into the disputed domain name is sufficient to establish that the disputed domain name is identical to the registered trademark.
The addition of the ".site” generic top level domain, being a technical requirement, is irrelevant for the confusion/similarity comparison.
Therefore this Panel considers the disputed domain name to be identical to the Complainant's marks pursuant to paragraph 4(a)(i) of the Policy.
* * *
The Respondent has no connection or affiliation with the Complainant, which has not licensed or otherwise authorised the Respondent to use or apply for any domain name incorporating Complainant’s trademark.
The Respondent does not appear to make any legitimate use of the disputed domain name for non-commercial activities. Indeed, the disputed domain name does not appear to be used.
The Respondent does not appear to have been commonly known by the disputed domain name.
The Respondent has not proved, affirmed or even claimed to have legitimate rights or interests in the disputed domain name (within the meaning of paragraph 4(a)(ii)of the Policy).
Therefore, the Respondent has not shown any facts or elements to justify prior rights and/or legitimate interests in the disputed domain name in accordance with the UDRP Policy. The Respondent did not provide any elements to demonstrate, as required by the Policy, that it used or made preparations to use the disputed domain name or a name corresponding to it in connection with a bona fide offering of goods or services.
Accordingly, the Panel finds that the Complainant has satisfied the burden of proof with respect to paragraph 4(a)(ii) of the Policy.
* * *
Based on the evidence put forward by the Complainant, the Panel, on the balance of probabilities, finds that the Respondent was aware of the Complainant’s trademark registrations and rights to the LEXAPRO Mark when she registered the disputed domain name.
In fact, the Complainant’s trademark is a fanciful name with no meaning. It has been registered and used for several years and thus it long predates the disputed domain name’s registration. Therefore, in the absence of evidence to the contrary, the Panel finds that the Respondent knew of the Complainant’s trademark and intentionally intended to create an association with the Complainant and its business, and that the Respondent must have had actual knowledge of the Complainant’s trademark at the time of the registration of the disputed domain name, with respect to the use of the disputed domain name.
The disputed domain name is not actively used. However, as noted by the Complainant, it was first stated in Telstra Corporation Limited v. Nuclear Marshmallows (WIPO Case D2000-0003) and repeated in many subsequent decisions under the UDRP: “that the concept of a domain name ‘being used in bad faith’ is not limited to positive action; inaction is within the concept. That is to say, it is possible, in certain circumstances, for inactivity by Respondent to amount to the domain name being used in bad faith.”
Inference of bad faith registration and use of the disputed domain name is also given by the fact that the Respondent has not even responded to, let alone denied, the assertions of bad faith made by the Complainant in this proceeding. It is therefore reasonable to assume that if the Respondent had legitimate purposes for registering and using the disputed domain name, she would have responded.
Therefore this Panel considers that, owing to all of the above, the Respondent’s registration and use of the lexapro.site domain name falls within the parameters of bad faith use and registration within the meaning of the ICANN Policy.
Considering the foregoing, the Complainant has, to the satisfaction of the Panel, shown that the Domain Name was registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).
|